InvestorsHub Logo

ORCA

12/12/23 8:47 PM

#3665 RE: BULLMOVEMENT11 #3664

ME TOO.PER PR TWO MONTHS AGO.THE MERGER IS CLOSING THIS Q.ANY DAY NOW.WITH $20 MILLION COMPANY,DAMN.IF IT HAPPENS.IT LOOKS LIKE IT HAS BOTTOMED HERE.
READ BOLD PARTS.ALSO SS UPDATED YESTERDAY AND THE FLOAT IS ONLY 15,5 MILLION.THUS THE LAST TIME IT WENT FROM .05 TO .165 IN ONE DAY.

Nov 15 2023 0.055 -0.045 -45.0% 0.10 0.165 0.05 390,480
Outstanding Shares
412,260,668
12/11/2023
Restricted
396,768,111
12/11/2023
Unrestricted
15,492,557

12/11/2023
https://www.otcmarkets.com/stock/NBCO/security
HOPING THIS COMES TO FRUITION.IS DUE.Neon Bloom Signs Letter of Intent to Acquire Advanced Executive Sales, LLC
Press Release | 09/28/2023
Acquisition Expected to Initially Increase Annual Revenues by $20 Million this Year

COLUMBIA, MD / ACCESSWIRE / September 28, 2023 / Neon Bloom, Inc. (OTC PINK:NBCO), announced today that it has signed a Letter of Intent to acquire Advanced Executive Sales, LLC (AES), a leading financial services company specializing in generating transactional revenue for many types of businesses, both in the e-Commerce and Point of Sale space.

AES is a rapidly growing, leading provider which specializes in simple and secure products that bring the customer and participating merchant partners inside the same secure platform to handle real-time transactions and more. It anticipates booking $20 million in 2023 revenue in 2023. AES is a certified partner with YNLO Ultratech and Payshield and actively working with over 100 e-commerce sites.


Today's news follows the announcement a few weeks ago that its subsidiary, Bazelet™ Health Systems Inc., has recently firmly established itself in the $60B US Organic food and beverage industry in 2024 with the introduction of PECSA™ Organic, the first Federally legal, patent pending cannabinoid ingredient that is compliant with the FD&C Act.

Neon Bloom Director Fred Luke, commenting on the expansion move into Fintech said, "I have been collaborating with AES and one of its affiliates on projects recently, and the other members of the Neon Bloom Board and management team have been favorably impressed with AES's management, business and year-over-year growth in this rapidly growing space. AES has expanded its focus on e-Commerce and Point of Sale transaction solutions, which now enables it to provide secure interactions between merchants and customers, payment & Digital Wallet solutions that should be accessible and easy to use by everyone - especially those unable to qualify for traditional credit, credit cards or bank accounts".

Mr. Luke went on to say, "This transaction, as envisioned, is expected to immediately begin bringing in positive cash flow helping us implement operational infrastructure, provide working capital for our subsidiaries and to help us complete additional acquisitions we have been studying for some time now."

Under the terms of the Letter of Intent, NBCO intends to acquire all the Membership Interests of AES in a stock-for-membership interest structure utilizing a newly formed wholly owned subsidiary into which AES will be merger and continue to operate as "Advanced Executive Sales Inc.". The two companies intend to complete and close a formal purchase agreement by the end of the current quarter.

Greg Bauer, AES Founder and Managing Member, said, "AES is eager to scale our talent, resources, experience and customer base and, with the structure of this "marriage", joining forces with NBCO makes AES part of a publicly held company which allows access for the combined company to sources of working capital - equity and debt - that AES has not been able to access as a privately-held enterprise".


About Neon Bloom:
Neon Bloom, Inc. (OTC PINK:NBCO) is a diversified enterprise group, currently engaged in the development of new life-science technologies, technologically improved financial services, and other emerging business sectors. Beginning in 2020 NBCO began to expand its leadership team and its investments in new acquisitions; in 2021 it acquired Bazelet Health Systems, Inc. ("Bazelet") in an all-stock transaction, and currently operates Bazelet as a wholly owned subsidiary. The Company intends to make additional acquisitions in the near future utilizing shares of its common stock, non-convertible promissory performance-based notes, and cash as available.

About Bazelet Health Systems, Inc:
Bazelet, is the licensed US plant patent, trademark, and manufacturer of PAN2020, the world's first patented cannabis plant (US Plant Patent number US PP32,725 P2). PAN2020 is a new and distinct variety of cannabis sativa (L.) plant and contains 0.00% tetrahydrocannabinol (THC), making it the first and only federally legal cannabis plant. With Pan2020, Bazelet developed the proprietary ingredient PECSA (Plant-based EndoCannabinoid System Activator), used in the manufacturing and commercial supply of food, drug, and cosmetic products that comply with the Food, Drug and Cosmetic Act. There are no health care claims being made by the Company or Bazelet about the PECSA products; these products are not intended to treat, diagnose, mitigate, prevent, or cure diseases, nor do they have any therapeutic effect as to any specific medically diagnosed conditions.

CONTACT:
Shareholder Relations
E-MAIL: shholders@directequitysource.com
TELEPHONE 1- 888-404-3314

canthelpit

12/18/23 6:43 PM

#3670 RE: BULLMOVEMENT11 #3664

nbco nice call